Smith & Nephew SNATS Inc (SNN) is a Healthcare · Medical Devices company listed on NYSE. Price $27.56 (-0.79%), Market cap $13.11B, P/E ratio 21.51, 52-week low–high $28.58 ~ $38.70.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and impla
Financial statements, price targets, institutional (13F) holdings and related news for Smith & Nephew SNATS Inc are updated in real time on BlackAll Trade.
Smith & Nephew SNATS Inc trades at $27.56 (-0.79%). Real-time quotes and charts are available on BlackAll Trade.
Smith & Nephew SNATS Inc has a market cap of about $13.11B. Its P/E ratio is 21.51.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company o